Centre Never Sought Oxygen Death Data: Rajasthan & Chhattisgarh

JAIPUR/RAIPUR : Two Congress-led states on Thursday refuted the Centre’s statement in Parliament that “no deaths due to lack of oxygen were specifically reported by the states” during the second wave of Covid-19.

The health ministers of Rajasthan and Chhattisgarh claimed their states were never asked to submit the relevant data and hence did not report the number of Covid deaths medically attributed to oxygen shortage.

Both questioned the basis of the Centre’s statement in Parliament when the relevant data wasn’t collected from the states. Rajasthan health minister Raghu Sharma said majority of the deaths during the second wave in the state were due to oxygen shortage.

The Centre, in a written statement on Tuesday, had informed the Rajya Sabha that states did not specifically report deaths due to oxygen shortage. In a series of tweets on Thursday, Chhattisgarh health minister TS Singh Deo pointed out that the “number of deaths in a day, deaths with comorbidity, deaths without comorbidity and type of comorbidity” were the only categories in which data was sought. Singh Deo alleged that the Centre deliberately misled Parliament without checking with the states. “When GOI says ‘no one died due to lack of oxygen during the second wave,’ they are probably referring to Chhattisgarh — a state with surplus oxygen,” added Singh Deo.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 73 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 106 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt